Nanthealth Cash per Share

NH
 Stock
  

USD 0.28  0.01  3.70%   

Nanthealth fundamentals help investors to digest information that contributes to Nanthealth's financial success or failures. It also enables traders to predict the movement of Nanthealth Stock. The fundamental analysis module provides a way to measure Nanthealth's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanthealth stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
The current Free Cash Flow is estimated to decrease to about (28 M).

Nanthealth Cash per Share Analysis

Nanthealth's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
 2019 2020 2021 2022 (projected)
Interest Expense18.04 M19.2 M22.08 M18.12 M
Gross Profit43.29 M43.95 M50.54 M47.2 M
Cash per Share 
 = 
Total Cash 
Average Shares 
More About Cash per Share | All Equity Analysis

Current Nanthealth Cash per Share

    
  0.05 X  
Most of Nanthealth's fundamental indicators, such as Cash per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanthealth is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Nanthealth Cash per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Nanthealth is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Cash per Share. Since Nanthealth's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nanthealth's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nanthealth's interrelated accounts and indicators.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Compare to competition

Nanthealth Shareholders Equity

Shareholders Equity

3.34 Million

Nanthealth Shareholders Equity is most likely to decrease significantly in the upcoming years. The last year's value of Shareholders Equity was reported at 3.26 Million
In accordance with the recently published financial statements, Nanthealth has a Cash per Share of 0.05 times. This is 98.85% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The cash per share for all United States stocks is 99.0% higher than that of the company.

Nanthealth Current Valuation Drivers

We derive many important indicators used in calculating different scores of Nanthealth from analyzing Nanthealth's financial statements. These drivers represent accounts that assess Nanthealth's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nanthealth's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Average Assets530.33 M361.74 M274.55 M221.18 M199.07 M273.11 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(63.19 M)(144.23 M)(50.52 M)(51.72 M)(46.55 M)(50.22 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(133.19 M)(156.35 M)(23.37 M)(19.91 M)(22.9 M)(24.7 M)
Earnings before Tax(177.41 M)(195.82 M)(63.78 M)(55.88 M)(64.26 M)(69.33 M)
Average Equity267.85 M93.3 M(37.64 M)(80.1 M)(72.09 M)(73.98 M)
Enterprise Value451.21 M235.91 M321.66 M553.84 M498.46 M498.52 M
Free Cash Flow(94.78 M)(40.18 M)(13.36 M)(22.53 M)(25.9 M)(27.95 M)
Invested Capital363.08 M251.34 M270.73 M127.53 M114.78 M175.88 M
Invested Capital Average378.11 M309.82 M265.58 M209.07 M188.16 M221.71 M
Market Capitalization330.41 M59.59 M113.94 M359.22 M323.3 M344.33 M
Tangible Asset Value265.15 M105.7 M117.33 M53.99 M48.59 M49.87 M
Working Capital46.03 M2.91 M(19.59 M)(94.16 M)(84.75 M)(86.98 M)

Nanthealth Fundamentals

About Nanthealth Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nanthealth's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanthealth using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanthealth based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Free Cash Flow-25.9 M-28 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nanthealth in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nanthealth's short interest history, or implied volatility extrapolated from Nanthealth options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Nanthealth using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Nanthealth Piotroski F Score and Nanthealth Altman Z Score analysis. Note that the Nanthealth information on this page should be used as a complementary analysis to other Nanthealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Complementary Tools for Nanthealth Stock analysis

When running Nanthealth price analysis, check to measure Nanthealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanthealth is operating at the current time. Most of Nanthealth's value examination focuses on studying past and present price action to predict the probability of Nanthealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nanthealth's price. Additionally, you may evaluate how the addition of Nanthealth to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Is Nanthealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nanthealth. If investors know Nanthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nanthealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
31 M
Quarterly Revenue Growth YOY
0.16
Return On Assets
(0.17) 
The market value of Nanthealth is measured differently than its book value, which is the value of Nanthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Nanthealth's value that differs from its market value or its book value, called intrinsic value, which is Nanthealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nanthealth's market value can be influenced by many factors that don't directly affect Nanthealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nanthealth's value and its price as these two are different measures arrived at by different means. Investors typically determine Nanthealth value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanthealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.